Given that Pit-1 down-regulates DNA-damage and repair genes (i.e. BRCA1) and sensitizes breast cancer cells to DNA-damage agents, in this study we used the antineoplastic drug, cisplatin, which is frequently applied to BRCA1-associated breast tumors [29]. The gene discussed is POU1F1; the disease is breast cancer.